http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010524863-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2008-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010524863-A |
| titleOfInvention | Novel compounds for the treatment of psychiatric disorders and their preparation and use |
| abstract | The present invention relates to a compound represented by the formula (I), an optical isomer, or a pharmaceutically acceptable salt thereof, a preparation and use thereof. In the formula, R is defined as described in the specification. Such compounds can be presented as optical isomers or racemic mixtures. The compounds are metabolized in vivo, yielding pharmacologically active substances as neurotransmitter blockers and can be used for the treatment of psychiatric disorders such as schizophrenia. |
| priorityDate | 2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 190.